The End Drug Shortages Alliance has released a market analysis of products affected by the recent shuttering of a Teva pharmaceutical manufacturing plant in Irvine, California, urging increased supply chain transparency to nip any resulting shortages in the bud. The closure is expected to impact 25 pharmaceutical injectables previously manufactured at the plant.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?